We need to build houses people can afford | Letters
Richard Eltringham on the housing crisis not being addressed, and Ryan McKiernan on the need for sustained investment in...
Are you worried about rising fuel costs?
Energy costs jump as oil supplies from the Middle East are disrupted by failed US-Iran ceasefire talks.
Shipping Companies Remain Reluctant to Sail Through Strait of Hormuz
The United States said it would begin blocking vessels doing business with Iran. Details on how that would work are uncl...
Trump Administration’s Temporary Reprieve on Russian Oil Expires
A sanctions waiver aimed at keeping global oil prices down had allowed Moscow to sell oil currently at sea.
Meta creating AI version of Mark Zuckerberg so staff can talk to the boss
Digital clone being trained on his thoughts, tone and mannerisms to help workers feel connectedIf you are one of Meta’s ...
Judge Dismisses Trump’s Suit Over WSJ Report on Birthday Card to Epstein
The judge said President Trump had not “plausibly alleged” that The Journal published the article with actual malice.
‘That crazy old man should leave Cuba alone’: farmers bear the brunt of Trump’s pressure campaign
In Artemisa, the country’s agricultural heartland, sanctions and fuel shortages have made a tough life almost impossible...
Delta Air Lines unveils first new Delta One suite in premium cabin arms race
Delta Air Lines on Monday unveiled an updated Delta One suite for some of its longest-haul planes, marking its first ref...
Hollywood Heavyweights Sign Letter Opposing Paramount’s Deal for Warner Bros.
The letter warns that the deal will result in fewer jobs for creatives, along with higher costs and less choice for audi...
EasyJet passengers describe EU border 'nightmare'
EasyJet passengers describe EU border 'nightmare'1 hour agoShareSaveAdd as preferred on GoogleEwan Gawne,Mat T...
Goldman Sachs Earnings Show Effects of Iran War
It will be a tricky earnings season, as the investment banking giant became the first to show on Monday.
Revolution Medicines' potential breakthrough pancreatic cancer drug succeeds in late-stage trial
Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, almost doubling t...